Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Hearing loss (hearing impairment) and Inner ear hearing loss (sensorineural hearing impairment). 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 3 | Abnormal vestibular function, Hearing loss (hearing impairment), Inner ear hearing loss (sensorineural hearing impairment) |
PDZD7 function has not been fully characterized.
Hearing loss, autosomal recessive 57 is associated with mutations in the PDZD7 gene on chromosome 10.
Genetic testing for PDZD7 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for hearing loss, autosomal recessive 57 has been reported in the published literature.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for hearing loss, autosomal recessive 57.
13 publications have been identified in PubMed for hearing loss, autosomal recessive 57. Research spans Basic Science / Preclinical (31%), Diagnostic / Biomarker (15%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 4 | 31% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:05 PM UTC
Online Mendelian Inheritance in Man
Eyes
2 |
Visual impairment, Abnormal retinal morphology |
Age of onset: infancy.
Testing and diagnosis research
2 |
15% |
Patient case studies | 2 | 15% |
Clinical study results | 2 | 15% |
Disease patterns and progression | 2 | 15% |
Research summaries | 1 | 8% |
Marsal-Olivan A (2026). [PMID: 42071123](https://pubmed.ncbi.nlm.nih.gov/42071123/). *J Assist Reprod Genet*. [Diagnostic / Biomarker]
Bae HG (2025). [PMID: 40360853](https://pubmed.ncbi.nlm.nih.gov/40360853/). *J Assoc Res Otolaryngol*. [Basic Science / Preclinical]
Wang W (2025). [PMID: 40389765](https://pubmed.ncbi.nlm.nih.gov/40389765/). *J Assist Reprod Genet*. [Diagnostic / Biomarker]
Gregory-Evans CY (2025). [PMID: 40606475](https://pubmed.ncbi.nlm.nih.gov/40606475/). *Mol Vis*. [Case Report / Case Series]
Courdier C (2025). [PMID: 39610034](https://pubmed.ncbi.nlm.nih.gov/39610034/). *Ophthalmic Genet*. [Basic Science / Preclinical]
Long X (2025). [PMID: 40410890](https://pubmed.ncbi.nlm.nih.gov/40410890/). *Hum Genomics*. [Basic Science / Preclinical]
Liu Y (2025). [PMID: 40555484](https://pubmed.ncbi.nlm.nih.gov/40555484/). *Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Case Report / Case Series]
Qi J (2025). [PMID: 40603731](https://pubmed.ncbi.nlm.nih.gov/40603731/). *Nat Med*. [Clinical Trial Publication]
Mendes Ferreira V (2025). [PMID: 40064796](https://pubmed.ncbi.nlm.nih.gov/40064796/). *Acta Neurol Belg*. [Review / Meta-Analysis]
Lv J (2024). [PMID: 38280389](https://pubmed.ncbi.nlm.nih.gov/38280389/). *Lancet*. [Clinical Trial Publication]